In the U.K., between 2007 and October 2025, 1,296 yellow card reports of pancreatitis linked to GLP-1 receptor agonists or dual GLP-1/GIP receptor agonists were reported, of which 19 were fatal
Our meta-analysis integrating data from FinnGen, PGC, and UK Biobank cohorts enhanced statistical power by mitigating cohort-specific biases
Subsequent advancements include long-acting formulations like liraglutide and semaglutide
At the same time, rapid weight loss, regardless of method, introduces important considerations for muscle and nutritional health
This stack consists of the peptides BPC-157, TB-500 and GHK-Cu (copper peptide)
In light of the bidirectional relationship between NAFLD and sarcopenia and the significantly higher cardiovascular risk in obese sarcopenic patients compared to non-sarcopenic ones [143], GLP-1 RAs could guarantee additional direct benefits independent from weight loss and glycaemic control